Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Dent Mater ; 35(12): 1695-1705, 2019 12.
Article in English | MEDLINE | ID: mdl-31563405

ABSTRACT

OBJECTIVE: To compare ion release characteristics of three different dental varnishes either containing CPP-ACP and fluoride (CPP-ACPF, MI Varnish GC, Japan), bioactive glass and fluoride (BGAF, Dentsply Sirona USA) or fluoride alone (NUPRO White, Dentsply Sirona USA) using fluoride-Ion Selective Electrode (F-ISE), Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES), X-ray diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), 19F and 31P Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR). METHODS: A thin layer (0.0674±0.0005g) of each varnish (20×25mm in area) was spread on a roughened glass slide (n=7). They were separately immersed in 10ml Tris buffer (0.06M, pH=7.30), and changed after 1, 2, 4, 6, 24 and 48h. Fluoride-ion concentration at each time using the F-ISE, whilst calcium and phosphate release were investigated using ICP-OES. XRD, FTIR. MAS-NMR analyses were also performed before and after immersion. RESULTS: The cumulative F-ion release was significantly higher in CPP-ACPF (1.113mmol/g)>BGAF(0.638)>F(0.112) (p<0.001). The cumulative calcium and phosphorus were higher in the CPP-ACPF (0.137mmol/g, 0.119) than BGAF (0.067, 0.015) (p<0.001) respectively. The XRD and 19F MAS-NMR confirmed the presence of NaF peaks in all cases before immersion. There were less prominent signal and appearance of fluorapatite crystals after immersion. 19F MAS-NMR revealed CaF2 formation after immersion in both CPP-ACPF and BGAF. 31P MAS-NMR showed phosphate signals in both CPP-ACPF and BGAF before immersion. FTIR failed to show any signs of apatite formation. SIGNIFICANCE: Both CPP-ACP and bioactive glass enhanced ion release without compromising the bioavailability of fluoride. The CPP-ACPF varnish had the most promising ion release.


Subject(s)
Fluorides , Glass , Caseins , Phosphates
2.
Oper Dent ; 43(6): E308-E316, 2018.
Article in English | MEDLINE | ID: mdl-30457948

ABSTRACT

OBJECTIVES:: The objective of this in vitro study was to quantify the amount of mineral change in demineralized dentin at pH 5.5 after the application of dental varnishes containing fluoride with casein phosphopeptide-amorphous calcium phosphate, fluoride and bioglass, or fluoride alone. METHODS AND MATERIALS:: A total of 12 extracted human sound mandibular premolar root samples were coated with an acid-resistant varnish, leaving a 2 × 3 mm window at the outer root surface. These root specimens were then randomly divided into four groups and separately subjected to the demineralizing cycle at a pH of 4.8 for five days to create artificial caries-like lesions in dentin. Subsequently, each sample was imaged using quantitative x-ray microtomography (XMT) at a 15-µm voxel size. Each test group then received one of the following treatments: dental varnish containing casein phosphopeptide-amorphous calcium phosphate and fluoride (CPP-ACP, MI varnish, GC Europe), bioglass and fluoride (BGA, Experimental, Dentsply Sirona), or fluoride alone (NUPRO, Dentsply Sirona), as well as a control group, which received no treatment. These samples were kept in deionized water for 12 hours. The thin layer of varnish was then removed. All samples including the nonvarnish group were subjected to the second demineralizing cycle at pH 5.5 for five days. The final XMT imaging was then carried out following the second demineralizing cycle. XMT scan was also carried out to varnish samples at 25 µm voxel size. The change in mineral concentration in the demineralized teeth was assessed using both qualitative and quantitative image analysis. RESULTS:: There was an increase in radiopacity in the subtracted images of all varnish groups; a significant increase in mineral content, 12% for the CPP-ACP and fluoride ( p≤0.05 and p≤0.001), 25% BGA ( p≤0.001), and 104% fluoride alone varnish ( p≤0.001). There was an increase in the size of radiolucency in the lesion area with a significant decrease in mineral content in the nonvarnish group, 10% ( p≤0.05 and p≤0.001). CONCLUSIONS:: There was encouraging evidence of a remineralization effect following the application of dental varnish on dentin and also an observed resistance to demineralization during the acidic challenge in all cases. However, a dental varnish containing fluoride alone appeared to have a much greater effect on dentin remineralization when compared with CPP-ACP with fluoride and bioglass with fluoride.


Subject(s)
Bicuspid/diagnostic imaging , Caseins/chemistry , Ceramics/chemistry , Fluorides, Topical/chemistry , Tooth Remineralization/methods , X-Ray Microtomography , Humans , Hydrogen-Ion Concentration , In Vitro Techniques , Materials Testing , Surface Properties
3.
J Dent ; 73: 91-96, 2018 06.
Article in English | MEDLINE | ID: mdl-29673685

ABSTRACT

OBJECTIVES: To compare the efficacy of fluoride varnishes either casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) or bioglass particles on the severity index of root caries. METHODS: Visual-tactile assessments including lesion hardness was carried out to categorise the severity index of 80 extracted teeth with primary root caries. These teeth were randomly divided into four groups; CPP-ACP and fluoride, bioglass and fluoride, fluoride only, and no treatment. Standardised toothbrushing using a dentifrice containing 1450 ppm fluoride was carried out twice a day for all groups. All samples were stored in remineralising solution at 37°C for 45 days. Visual-tactile assessments were carried out at baseline, and after 45 days. Surface roughness measurements (Ra) were performed at baseline and after 7, 14, 30 and 45 days. X-ray Microtomography was performed at the baseline and after 45 days for three samples from each group to quantify the change in mineral contents in the lesion area. RESULTS: The Visual-tactile assessment results showed a reduction in the severity index of root caries, being 20% in CPP-ACP and fluoride, 100% in bioglass and fluoride, 80% in fluoride only, and 60% in non-varnish (toothbrushing only). Non-significant change in surface roughness was observed in all groups. X-ray Microtomography assessment showed a highly significant increase in the mineral deposition in all cases (p > .001). CONCLUSION: The combination of bioglass with fluoride has a potentially superior effect than either CPP-ACP with fluoride or fluoride only to reverse and arrest the root caries in a laboratory setting. CLINICAL SIGNIFICANCE: The combination of bioglass particles and fluoride formulation is likely to have a significant impact in reversing and arresting root caries in a minimally invasive approach. However, randomised controlled double-blinded clinical trials are required to translate these results into clinical practice.


Subject(s)
Caseins/therapeutic use , Ceramics/therapeutic use , Fluorides, Topical/therapeutic use , Fluorides/therapeutic use , Root Caries/drug therapy , Dentifrices/therapeutic use , Hardness , Humans , Minerals , Reproducibility of Results , Root Caries/diagnostic imaging , Surface Properties , Tooth Remineralization/methods , Toothbrushing , X-Ray Microtomography
6.
Oral Dis ; 22 Suppl 1: 19-24, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27109269

ABSTRACT

Management of HIV in India has significantly improved with many international and local programmes supporting prevention and treatment. However, there are areas in India where women and children living with HIV endure a myriad of medical, psychological and social challenges. Women in rural poor areas in India have little control over important aspects of their life. Often, they have little decision-making powers within their families on matters that affect them personally. They find themselves unable to negotiate to protect themselves from harm or risk of infection. Those who are known to have contracted HIV are reluctant to access health care for fear of discrimination and marginalization, leading to a disproportionate death rate in HIV women. India is arguably home to the largest number of orphans of the HIV epidemic. These children face an impenetrable barrier in many Indian societies and endure stigmatization. This situation encourages concealment of the disease and discourages children and their guardians from accessing available essential services. This article provides an overview of the relevant literature and presents an insight into a complex mix of issues that arise directly out of the HIV diagnosis, including the role of social attitudes in the spread of HIV, and in creating barriers to accessing care. The review identifies international programmes and local initiatives that have ensured better access to antiretroviral therapy and have led to prolonged survival and reduction in the vertical transmission of HIV in India.


Subject(s)
HIV Infections/drug therapy , HIV Infections/transmission , Infectious Disease Transmission, Vertical/prevention & control , Patient Acceptance of Health Care/psychology , Adolescent , Anti-HIV Agents/therapeutic use , Child , Child, Preschool , Female , HIV Infections/epidemiology , HIV Infections/prevention & control , Health Services Accessibility , Humans , India/epidemiology , Infant , Infant, Newborn
7.
Oral Dis ; 22 Suppl 1: 211-4, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27109289

ABSTRACT

The Research Agenda generated by the 7th World Workshop on Oral Health and Disease in AIDS (WW7) is delivered in this paper. Panels of international experts presided over nine workshops that constituted the conference held in November 2014 in Hyderabad, India. The main goal of the Workshop was to bring together clinician and scientists interested in the subject to debate with world-wide perspectives current issues related to the oral manifestations in HIV/AIDS. The workshops were structured around three themes; basic science, clinical/translational science and social science and were attended by 135 participants from 31 countries. The research questions debated at the workshops are presented in nine consensus papers published in this issue and are summarised in this paper along with an outline of the identified research needs in the field.


Subject(s)
Anti-HIV Agents/therapeutic use , Biomedical Research , Dental Caries/epidemiology , HIV Infections/drug therapy , Mouth Diseases/epidemiology , Anti-HIV Agents/adverse effects , Bioethical Issues , Comorbidity , Consensus , Dental Caries/immunology , Gastrointestinal Microbiome , HIV Infections/epidemiology , HIV Infections/immunology , Health Services Accessibility , Healthcare Disparities , Humans , Immunity, Innate , Mouth Diseases/immunology , Mouth Diseases/microbiology
10.
Clin Exp Immunol ; 177(3): 618-29, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24827536

ABSTRACT

The suppressor of cytokine signalling 3 (SOCS3) negatively regulates the Janus kinase (JAK)/signal transducer and activator of transcription-3 (STAT-3)/interleukin (IL)-17 pathway. The proinflammatory cytokine IL-17 is over-expressed in Sjögren's syndrome (SS) and is a key factor in its pathogenesis. We hypothesized that IL-17 over-expression in SS results from ineffective regulation by SOCS3. The expression of SOCS3 was analysed in peripheral blood mononuclear cells (PBMC) from SS cases, sicca controls (SC) and healthy controls (HC) and tissue samples from SS, SC and healthy salivary glands (HSG). PBMC and salivary gland tissue from SS and controls were dual-immunostained for SOCS3 and IL-17. IL-6-stimulated PBMC from SS and controls were evaluated for time-dependent STAT-3 activation and SOCS3 induction, and for IL-17 expression. Immunoblotting revealed greater levels of SOCS3 in PBMC from SS than SC (P = 0·017) or HC (P < 0·001). Similarly, the proportion of salivary-gland tissue cells staining for SOCS3 was significantly higher in SS than SC (P = 0·029) or HSG (P = 0·021). The cells in PBMC/salivary gland samples from controls predominantly expressed either SOCS3 or IL-17. However, there was a high frequency of SOCS3/IL-17 co-expression within cells of SS samples. IL-6-stimulation of PBMC from SS cases revealed prolonged activation of STAT-3 with reduced negative regulation by SOCS3, and enhanced expression of IL-17. This study showed that SOCS3 expression is up-regulated in SS. However, the absence in SS of the normal inverse relationship between SOCS3 and pSTAT-3/IL-17 indicates a functional disturbance in this signalling cascade. Consequently, a reduction in function, rather than a reduction in expression of SOCS3 accounts for the unregulated expression of IL-17 in SS, and may play a crucial role in aetiopathogenesis.


Subject(s)
STAT3 Transcription Factor/metabolism , Signal Transduction , Sjogren's Syndrome/immunology , Sjogren's Syndrome/metabolism , Suppressor of Cytokine Signaling Proteins/metabolism , Adult , Aged , Female , Humans , Interleukin-17/metabolism , Interleukin-6/metabolism , Interleukin-6/pharmacology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Salivary Glands/metabolism , Sjogren's Syndrome/diagnosis , Suppressor of Cytokine Signaling 3 Protein
11.
Med Confl Surviv ; 29(1): 57-68, 2013.
Article in English | MEDLINE | ID: mdl-23729098

ABSTRACT

A collaborative project funded by the Iraqi Research Fellowship Programme of the Council for Assisting Refugee Academics was set up to transfer laboratory and clinical skills in between three clinical research teams in the UK, Jordan and Iraq. The project was set up to study the genetics of the potentially debilitating condition, Behçet's Disease (BD). Blood samples were collected from: 38 BD patients, 28 patients with oral ulcers not related to BD and 32 healthy controls. All samples were analysed using Micro SSP HLA Class I B locus kit (B locus, generic). Logistic regression analysis revealed that samples positive for HLA-B51 were 7.4 times more likely to have BD than the healthy control subjects. The results of this study make a valuable addition to the scientific literature. Additional valuable outcomes include the intellectual exchange and transfer of skills in between the collaborating teams, which led to the establishment of an international research collaboration.


Subject(s)
Behcet Syndrome/genetics , HLA-B51 Antigen/genetics , International Cooperation , Biomedical Research/education , Case-Control Studies , Female , Genetic Testing , Humans , Iraq , Jordan , Male , United Kingdom
12.
Adv Dent Res ; 23(1): 90-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21441488

ABSTRACT

Immune reconstitution inflammatory syndrome (IRIS) is a phenomenon observed in patients recovering from immunodeficiency. The clinical presentation of IRIS involves the unmasking of covert infections or the worsening of overt conditions. Several causes and pathways have been suggested, most recognizing an inflammatory flare component occurring in the context of rapid immune reconstitution. In HIV-infected patients, IRIS inadvertently occurs as the consequence of successful antiretroviral therapy, and it is affiliated with improvement of the immune function, complicating the course of the disease and presenting treatment challenges to clinicians. The pathogenesis of IRIS is poorly understood, but in recovering HIV patients, its initiation and progression seem to be primarily linked to an increase in CD4+ T-helper and CD8+ T-suppressor cell count and a reduction in T-regulatory cells, all endorsed by exaggerated cytokine release and activity. The clinical presentation of IRIS is usually atypical. The manifestations depend on the trigger antigen, which can be an infective agent (viable or nonviable), a host antigen, or a tumor antigen. Most IRIS cases are self-limiting, but a few cases can be overwhelming and life-threatening; hence, early recognition is important. In most cases, there is no need to discontinue the antiretroviral therapy, although in the more severe cases, other clinical intervention may be necessary.


Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , Immune Reconstitution Inflammatory Syndrome , Mouth Neoplasms/etiology , Virus Diseases/etiology , CD8-Positive T-Lymphocytes/physiology , Cytokines/metabolism , HIV Infections/drug therapy , Humans , Immune Reconstitution Inflammatory Syndrome/etiology , Immune Reconstitution Inflammatory Syndrome/pathology , Immune Reconstitution Inflammatory Syndrome/physiopathology , Inflammation Mediators/metabolism , Lymphocyte Count , T-Lymphocytes, Helper-Inducer/physiology
13.
Adv Dent Res ; 23(1): 165-71, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21441499

ABSTRACT

Antiretroviral therapy (ART) has improved survival and changed the disease pattern of HIV infection. However, ART may cause serious side effects, such as metabolic and cardiovascular complications. In addition, immune reconstitution inflammatory syndrome (IRIS) is being increasingly reported in relation to ART. The article presents the consensus of a workshop around 4 key issues: (1) the differences in the response of adults and children to highly active antiretroviral therapy, (2) the mechanism of the new HIV entry inhibitors and its effect on oral markers, (3) the pathogenesis of IRIS and the contradictory findings of the possible oral lesions related with IRIS, (4) and the benefits and barriers associated with using ART in the developing and developed world. The consensus of the workshop was that there is a need for future studies on the oral manifestations of HIV in individuals treated with new ARTs-especially, children. IRIS was considered a promising field for future research; as such, workshop attendees recommended formulating an IRIS-oral lesions case definition and following strict criteria for its diagnosis.


Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , Developing Countries , HIV Fusion Inhibitors/pharmacology , HIV Infections/drug therapy , Immune Reconstitution Inflammatory Syndrome/etiology , Adult , Age Factors , Biomarkers , CCR5 Receptor Antagonists , Child , Focus Groups , HIV Fusion Inhibitors/therapeutic use , HIV Infections/diagnosis , Humans , Immune Reconstitution Inflammatory Syndrome/pathology
14.
J Microsc ; 230(Pt 2): 203-11, 2008 May.
Article in English | MEDLINE | ID: mdl-18445148

ABSTRACT

Malignant and dysplastic epithelial lesions have often been reported to excite vascular responses by histopathological characterization. Little is reported concerning in vivo real-time imaging of vascular patterns and flow in health or disease but the development of miniature imaging instrumentation has now allowed such developments. We describe the application of a selective wavelength (540 nm) epi-illumination Hopkins pattern endoscopic imaging system to image vascular tissues and capillary blood flow in vivo. The contrast mechanism in such imaging was characterized, haemoglobin acting as a chromatic transmission filter despite endoscopy being a non-invasive and therefore principally reflection mode imaging system. In vivo adrenergic vascular responses, capillary flow rate variations over time and variations in normal capillary architecture around the oral cavity were recorded; demonstrating that simple imaging systems can be used for non-surgical diagnosis and characterization of vascular lesions, tumours and treatment responses.


Subject(s)
Capillaries/physiology , Endoscopy/methods , Mouth Mucosa/blood supply , Mouth Mucosa/pathology , Diagnostic Imaging , Endoscopes , Epinephrine/administration & dosage , Erythrocytes/physiology , Hemoglobins , Humans , Image Processing, Computer-Assisted , Lidocaine/administration & dosage , Mouth Neoplasms/diagnosis , Neovascularization, Pathologic , Vasoconstrictor Agents/administration & dosage
15.
Br J Dermatol ; 157(4): 765-70, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17711534

ABSTRACT

BACKGROUND: To date, there is only weak evidence for the superiority of any interventions over placebo for the palliation of symptomatic oral lichen planus (LP). Further research involving large placebo-controlled, randomized clinical trials is needed. These will require carefully selected and standardized outcome measures. OBJECTIVES: To formulate a scoring system for intraoral LP. METHODS: One hundred and fifty-six patients with biopsy-confirmed LP were scored at the first and subsequent visits according to (i) extent of site involvement, (ii) disease activity at each site and (iii) an overall pain score as reported by the patient. Overall differences between clinical variants of LP were analysed using the Kruskal-Wallis test and pairwise differences by the Mann-Whitney U-test. Clinical sensitivity (Wilcoxon signed-rank test) was assessed by scoring patients before and after treatment (n = 23). RESULTS: Reticular LP (n = 48) was the commonest single type of clinical presentation, followed by ulcerative (n = 30), atrophic (n = 22), desquamative (n = 18) and plaque (n = 1). The median severity and activity scores were 13/6 (reticular), 39/20 (ulcerative), 20/9 (atrophic) and 23/11 (desquamative). Two or more clinical variants were seen in 37 cases. Statistical significance was observed for differences between clinical variants (P < 0.0001) and variation in scores (P < 0.01) when ulcerative LP was compared with all other types. Clinical sensitivity was statistically significant (P < 0.01), while reproducibility was high and allowed the response to therapy to be easily assessed. CONCLUSIONS: It is suggested that this scoring system is easy to use, reproducible and sensitive enough to detect clinical responses to therapy.


Subject(s)
Lichen Planus, Oral/pathology , Severity of Illness Index , Female , Humans , Lichen Planus, Oral/therapy , Male , Mouth Mucosa/pathology , Pain Measurement/methods , Reproducibility of Results , Sensitivity and Specificity , Tongue Diseases/pathology , Treatment Outcome
16.
Oral Dis ; 13(1): 93-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17241437

ABSTRACT

AIM: To develop and evaluate an objective method for assessing lip size and treatment-related morphological changes in orofacial granulomatosis (OFG) patients. MATERIALS AND METHODS: Patients with swollen lips because of OFG (n=21) were enrolled. A light-body polyvinylsiloxane material was used to take lip impressions before and after treatment (n=10), or during treatment (n=11). Plaster models were cast from the impressions and the lips were measured using callipers. The intra-examiner and inter-examiner reproducibility of the technique were assessed. RESULTS: OFG patients had significantly larger lips than controls (P<0.0001). The coefficient of variation on repeated measurements of the same impression was 1.6% and for duplicate impressions was 2.6%. Significant reduction in lip size was shown in all 10 patients after diet restriction (P<0.002). Seven of 11 patients whose impressions were taken at least 3 months after the initiation of cinnamon- and benzoate-free diet also showed reduction in lip size during follow up (P<0.002). CONCLUSIONS: Serial lip impressions appear to be reliable for routine quantification of morphological changes of the lips in OFG patients. We present a new reproducible and sensitive method for assessing changes in lip size in response to treatment in OFG.


Subject(s)
Granulomatosis, Orofacial/pathology , Lip/pathology , Models, Anatomic , Adolescent , Adult , Aged , Aged, 80 and over , Benzoates/adverse effects , Cephalometry/instrumentation , Cinnamomum zeylanicum/adverse effects , Dental Impression Materials , Feeding Behavior , Female , Follow-Up Studies , Granulomatosis, Orofacial/diet therapy , Humans , Male , Middle Aged , Observer Variation , Polyvinyls , Reproducibility of Results , Siloxanes , Treatment Outcome
17.
Adv Dent Res ; 19(1): 146-51, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16672565

ABSTRACT

Highly active anti-retroviral therapy (HAART) has revolutionized the treatment and prognosis of HIV disease and AIDS in those who can take advantage of the treatment. There are currently 20 different anti-retroviral drugs in 4 different classes that are used in specific combinations. Suppression of HIV replication and immune reconstitution are goals of therapy. Since the prevalence of some easily detectable oral manifestations of HIV/AIDS (OMHIV/AIDS) decreases with HAART, it has been suggested that they might be clinically useful surrogate markers of HAART efficacy and immune status. This might be particularly useful if their recurrence presaged or accompanied HAART failure. To date, there has been little work in this area, but its potential value to the clinical management of HIV/AIDS is apparent, especially if frequent measures of viral load and CD4 cell counts are not readily available. However, the usefulness of OMHIV/AIDS as signals for HAART failure is complicated by three phenomena: the immune reconstitution syndrome, the similarity of some adverse reactions of HAART to OMHIV/AIDS, and the direct inhibitory effect of HAART medications on some OMHIV/AIDS (e.g., inhibition of oral candidosis by protease inhibitors). This workshop considered the current evidence and proposed pertinent research questions.


Subject(s)
Antiretroviral Therapy, Highly Active , Biomarkers , HIV Infections/complications , HIV Infections/drug therapy , Mouth Diseases/complications , Anti-HIV Agents/adverse effects , Anti-HIV Agents/classification , Antiretroviral Therapy, Highly Active/adverse effects , CD4 Lymphocyte Count , Candidiasis, Oral/immunology , Humans , Immune System Diseases/chemically induced , Inflammation/chemically induced , Melanosis/etiology , Mouth Diseases/drug therapy , Mouth Diseases/etiology , Papillomavirus Infections/etiology , Salivary Gland Diseases/etiology , Syndrome , Treatment Failure , Viral Load , Xerostomia/etiology
18.
Oral Dis ; 8 Suppl 2: 115-9, 2002.
Article in English | MEDLINE | ID: mdl-12164644

ABSTRACT

The workshop agreed that the development of consensus quantification protocols was desirable, but that this whole field was underdeveloped, to date. The working goals were therefore redefined (vide infra). Three possible protocols were presented and discussed relating to oral hairy leukoplakia, oral ulceration (NOS) and oral candidiasis. There was agreement that different data-set protocols would have to be developed for specific HIV-related mucosal diseases. Furthermore, the data set should be consistent, standardized and disaggregated. In this way, with everyone working to the same standards of outcome, data from geographically, nationally, socially or culturally different areas could be readily compared. A future meeting to generate the disease-specific protocols would, most likely, be needed.


Subject(s)
AIDS-Related Opportunistic Infections/classification , Consensus , Guidelines as Topic , HIV Infections/complications , Mouth Diseases/classification , Antiretroviral Therapy, Highly Active , Candidiasis, Oral/classification , Data Collection/standards , Data Collection/statistics & numerical data , Global Health , Humans , Immunocompromised Host , Leukoplakia, Hairy/classification , Oral Ulcer/classification , Prognosis , Reproducibility of Results
19.
Article in English | MEDLINE | ID: mdl-11740479

ABSTRACT

OBJECTIVE: The purpose of this study was to compare the prevalence of oral manifestations in human immunodeficiency virus (HIV)-infected patients on monotherapy, dual therapy, or triple therapy with the prevalence of those not on antiretroviral therapy (ART). STUDY DESIGN: A cross-sectional study of the oral manifestations of HIV was carried out on 284 HIV-infected patients, 89 of whom were undergoing ART (12 on monotherapy, 41 on dual therapy, and 36 on triple therapy) and 195 who were not undergoing ART. Oral manifestations were recorded by using established presumptive clinical criteria. Chi-square statistical tests and separate bivariate analyses were conducted by using the Spearman rank correlation to describe the relationship between the prevalence of oral lesions and ART. RESULTS: The detection of oral manifestations was significantly decreased in subjects on dual therapy and subjects on triple therapy in comparison with patients on monotherapy (P <.05) and those on no ART regimen (P =.014). Oral manifestations were also significantly increased, with CD4 counts <200 cells/mm(3) and a viral load >3000 copies/mL (P <.001). CONCLUSIONS: Compared with the non-ART group, subjects on combination ART had significantly fewer HIV-related oral manifestations-probably as a result of an expression of their reconstituted immune system.


Subject(s)
Anti-HIV Agents/administration & dosage , Antiretroviral Therapy, Highly Active/methods , HIV Infections/complications , HIV Infections/drug therapy , Mouth Diseases/epidemiology , Mouth Diseases/prevention & control , Adolescent , Adult , Aged , Analysis of Variance , CD4 Lymphocyte Count , Candidiasis, Oral/epidemiology , Candidiasis, Oral/prevention & control , Cross-Sectional Studies , Drug Therapy, Combination , Female , Gingivitis, Necrotizing Ulcerative/epidemiology , Gingivitis, Necrotizing Ulcerative/prevention & control , Humans , Leukoplakia, Hairy/epidemiology , Leukoplakia, Hairy/prevention & control , London/epidemiology , Male , Middle Aged , Mouth Diseases/complications , Prevalence , Statistics, Nonparametric , Viral Load
20.
Article in English | MEDLINE | ID: mdl-10710457

ABSTRACT

Exostoses of the maxilla and mandible are nodular protuberances of mature bone that need to be accurately distinguished from other more diagnostically significant lesions, notably exosteal osteomas. Multiple dermatofibromas are rare and may be associated with altered immune function. We report the case of an otherwise healthy 47-year-old woman who was first seen with multiple maxillary and mandibular exostoses associated with multiple dermatofibromas. This association has not been previously reported.


Subject(s)
Exostoses/complications , Histiocytoma, Benign Fibrous/complications , Mandibular Diseases/complications , Maxillary Diseases/complications , Skin Neoplasms/complications , Exostoses/pathology , Female , Follow-Up Studies , Histiocytoma, Benign Fibrous/pathology , Humans , Mandibular Diseases/pathology , Maxillary Diseases/pathology , Middle Aged , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...